Literature DB >> 9643624

Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

J Barnes1, S Y Mills, N C Abbot, M Willoughby, E Ernst.   

Abstract

AIMS: To determine whether adverse drug reactions (ADRs) to herbal remedies would be reported differently from similar ADRs to conventional over-the-counter (OTC) medicines by herbal-remedy users.
METHODS: Face-to-face interviews (using a structured questionnaire) with 515 users of herbal remedies were conducted in six pharmacy stores and six healthfood stores in the UK. The questionnaire focused on the likely course of action taken by herbal-remedy users after experiencing an ADR associated with a conventional OTC medicine and a herbal remedy.
RESULTS: Following a 'serious' suspected ADR, 156 respondents (30.3%) would consult their GP irrespective of whether the ADR was associated with the use of a herbal remedy or a conventional OTC medicine, whereas 221 respondents (42.9%) would not consult their GP for a serious ADR associated with either type of preparation. One hundred and thirty-four respondents (26.0%) would consult their GP for a serious ADR to a conventional OTC medicine, but not for a similar ADR to a herbal remedy, whereas four respondents (0.8%) would consult their GP for a serious ADR to a herbal remedy, but not for a similar ADR to a conventional OTC medicine. Similar differences were found in attitudes towards reporting 'minor' suspected ADRs.
CONCLUSIONS: Consumers of herbal remedies would act differently with regard to reporting an ADR (serious or minor) to their GP depending on whether it was associated with a herbal remedy or a conventional OTC medicine. This has implications for herbal pharmacovigilance, particularly given the increasing use of OTC herbal remedies. The finding that a high proportion of respondents would not consult their GP or pharmacist following ADRs to conventional OTC medicines is also of concern.

Mesh:

Substances:

Year:  1998        PMID: 9643624      PMCID: PMC1873549          DOI: 10.1046/j.1365-2125.1998.00715.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Complementary medicine.

Authors:  N C Abbot; A R White; E Ernst
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

2.  Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.

Authors:  C C Smith; P M Bennett; H M Pearce; P I Harrison; D J Reynolds; J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1996-10       Impact factor: 4.335

Review 3.  Health risks of herbal remedies.

Authors:  P A De Smet
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

4.  Complementary medicine in Europe.

Authors:  P Fisher; A Ward
Journal:  BMJ       Date:  1994-07-09

5.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

  5 in total
  49 in total

Review 1.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety.

Authors:  Joanne Barnes
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

Review 2.  St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

Authors:  L Henderson; Q Y Yue; C Bergquist; B Gerden; P Arlett
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

Review 3.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.

Authors:  Joanne Barnes
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

Review 4.  Pharmacovigilance of herbal medicines : a UK perspective.

Authors:  Joanne Barnes
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Adverse event reporting for herbal medicines: a result of market forces.

Authors:  Rishma Walji; Heather Boon; Joanne Barnes; Zubin Austin; G Ross Baker; Sandy Welsh
Journal:  Healthc Policy       Date:  2009-05

6.  Herbal medicines--they are popular, but are they also safe?

Authors:  Edzard Ernst
Journal:  Eur J Clin Pharmacol       Date:  2006-01       Impact factor: 2.953

Review 7.  Clinical risk management of herb-drug interactions.

Authors:  Peter A G M De Smet
Journal:  Br J Clin Pharmacol       Date:  2006-11-20       Impact factor: 4.335

8.  Safety implications regarding use of phytomedicines.

Authors:  Laura Cuzzolin; Silvana Zaffani; Giuseppina Benoni
Journal:  Eur J Clin Pharmacol       Date:  2005-12-03       Impact factor: 2.953

9.  Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.

Authors:  Bill Gurley; Martha A Hubbard; D Keith Williams; John Thaden; Yudong Tong; W Brooks Gentry; Philip Breen; Danielle J Carrier; Shreekar Cheboyina
Journal:  J Clin Pharmacol       Date:  2006-02       Impact factor: 3.126

10.  Increased bruising with the combination of long-chain omega-3 fatty acids, flaxseed oil and clopidogrel.

Authors:  Candace Necyk; Mark A Ware; John T Arnason; Ross T Tsuyuki; Heather Boon; Sunita Vohra
Journal:  Can Pharm J (Ott)       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.